Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study.
Chen X, Wang W, Zou Q, Zhu X, Lin Q, Jiang Y, Sun Y, Shen L, Wang L, Zou G, Lin X, Lin S, Li M, Wang Y, Xu R, Ao R, Wang R, Lin H, Huang S, Xu T, Li W, Xia M, Xia Y, Wang Z, Li B, Li J, Hu C.
Chen X, et al.
Signal Transduct Target Ther. 2024 Jun 19;9(1):148. doi: 10.1038/s41392-024-01865-6.
Signal Transduct Target Ther. 2024.
PMID: 38890298
Clinical Trial.